Tofacitinib as a Successful Treatment for Hyper-IgE Syndrome and Autoimmunity Associated with Constitutive Activation of JAK3. - Pei Y; Jin B; Abasi R; Cheng C; Zhuang H; Zeng S; Jiang M; Pei H; Jiang X (Journal of clinical immunology, 2026)